Lyell Immunopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. 

CEO
Lynn Seely
CEOLynn Seely
Employees
300
Employees300
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2018
Founded2018
Employees
300
Employees300

LYEL Key Statistics

Market cap
144.53M
Market cap144.53M
Price-Earnings ratio
-0.39
Price-Earnings ratio-0.39
Dividend yield
Dividend yield
Average volume
178.47K
Average volume178.47K
High today
$9.95
High today$9.95
Low today
$9.66
Low today$9.66
Open price
$9.82
Open price$9.82
Volume
23.02K
Volume23.02K
52 Week high
$38.40
52 Week high$38.40
52 Week low
$7.65
52 Week low$7.65

People also own

Based on the portfolios of people who own LYEL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.